ENTITY

Medigene AG (MDG1 GR)

Analysis

Health Care • Germany

Medigene AG operates as a biopharmaceutical company. The Company provides research, development, and commercialization of drugs for the treatment of cancer and autoimmune diseases.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00